Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2Other hematologic neoplasm 2Thoracic 1Other solid neoplasm 1Gastrointestinal 1Dermatologic 1

Conditions

Neoplasms 2

Interventions

Paclitaxel 57Gemcitabine 51Carboplatin 51Surveys and Questionnaires 48Docetaxel 37Bevacizumab 37pembrolizumab 33Nivolumab 29Cisplatin 28Fluorouracil 24Capecitabine 23Irinotecan 22Erlotinib Hydrochloride 22Sorafenib 20Leucovorin 19Afatinib 19Radiotherapy 18Pemetrexed 18Oxaliplatin 17Trastuzumab 16Ipilimumab 15regorafenib 14Blood Specimen Collection 14130-nm albumin-bound paclitaxel 14olaparib 13Interviews as Topic 13Cetuximab 13Albumin-Bound Paclitaxel 13atezolizumab 12Sunitinib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Fecal Microbiota Transplantation × Tumor-Agnostic × Clear all
NCT02770326 2025-04-08

Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection

Memorial Sloan Kettering Cancer Center

Phase NA Completed
10 enrolled 6 charts
Tumor-Agnostic

Neoplasms

NCT05273255 2025-03-28

Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy

University of Zurich

Phase NA Completed
18 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡